Bausch Health Companies (BHC) Treasury Shares (2010 - 2025)
Bausch Health Companies (BHC) posted Treasury Shares of $9.2 million for Q4 2025, up 13.58% sequentially from $8.1 million in Q4 2024, and up 13.58% YoY from $8.1 million in Q4 2024.
Bausch Health Companies (BHC) Treasury Shares (2010 - 2025) Analysis & Trends
Bausch Health Companies has reported Treasury Shares for 3 years, with the latest figure at $72.0 million in Q4 2015.
- Quarterly Treasury Shares changed N/A year-over-year to $72.0 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $72.0 million (changed N/A YoY) and the FY2015 annual result came in at $72.0 million, changed N/A from the prior year.
- Treasury Shares rose to $72.0 million in Q4 2015 per BHC's latest filing, from $20.0 million in the prior quarter.
- Over five years, Treasury Shares peaked at $9.2 million in Q4 2025 and troughed at $5.4 million in Q4 2021.
- A 5-year average of $7.8 million and a median of $8.1 million in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2022: Treasury Shares decreased 5.26% in 2021, then surged 53.7% in 2022.
- Over 3 years, Treasury Shares stood at $66.9 million in 2011, then sank by 70.1% to $20.0 million in 2013, then surged by 260.0% to $72.0 million in 2015.
- According to Business Quant data, Treasury Shares over the past three periods registered $72.0 million, $20.0 million, and $66.9 million for Q4 2015, Q2 2013, and Q3 2011 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 19.00 Mn |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.10 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Dec 31, 2020 | 5.70 Mn |
| Dec 31, 2020 | 5.70 Mn |
| Dec 31, 2019 | 6.10 Mn |
| Dec 31, 2019 | 6.10 Mn |
| Dec 31, 2018 | 5.80 Mn |
| Dec 31, 2018 | 5.80 Mn |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2016 | 2.70 Mn |
| Dec 31, 2016 | 2.70 Mn |
| Dec 31, 2015 | 72.00 Mn |
| Dec 31, 2015 | 1.50 Mn |